Parataxis Holdings has announced a major step into South Korea’s public market. The New York-based digital asset firm will acquire a controlling stake in Bridge Biotherapeutics through a KRW 25
ACX lists on Bithumb’s KRW market with Ethereum-only transactions, marking a key step in South Korea’s booming crypto scene.
Parataxis Holdings has announced a major step into South Korea’s public market. The New York-based digital asset firm will acquire a controlling stake in Bridge Biotherapeutics through a KRW 25
ACX lists on Bithumb’s KRW market with Ethereum-only transactions, marking a key step in South Korea’s booming crypto scene.
Skip to content
